How should functionally equivalent drugs be reimbursed?: A retrospective analysis of reimbursement for epoetin alfa and Darbepoetin alfa in 2001–3 and the cost implications for CMS

Kanavos, Panos; and Saka, O (2005) How should functionally equivalent drugs be reimbursed?: A retrospective analysis of reimbursement for epoetin alfa and Darbepoetin alfa in 2001–3 and the cost implications for CMS. Disease Management and Health Outcomes, 13 (6). pp. 359-370. ISSN 1173-8790

Copy Share

Item Type	Article
Departments	LSE Health
Date Deposited	22 Jul 2008 13:41
URI	https://researchonline.lse.ac.uk/id/eprint/19513

Explore Further

• Kanavos, Panos
• Saka, O

• H Social Sciences (General)

Full text not available from this repository.

Atom BibTeX OpenURL ContextObject in Span OpenURL ContextObject Dublin Core MPEG-21 DIDL Data Cite XML EndNote HTML Citation METS MODS RIOXX2 XML Reference Manager Refer ASCII Citation

---

Export

Export this record

Downloads

edit Edit item (staff only)